Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

The Scotts Miracle-Gro Company (SMG)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
81.59-0.42 (-0.51%)
At close: 04:00PM EDT
81.68 +0.09 (+0.11%)
After hours: 05:12PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close82.01
Open82.79
Bid80.00 x 1000
Ask84.04 x 800
Day's Range80.55 - 82.79
52 Week Range72.58 - 180.43
Volume450,258
Avg. Volume569,845
Market Cap4.488B
Beta (5Y Monthly)1.21
PE Ratio (TTM)9.10
EPS (TTM)8.96
Earnings DateFeb 01, 2022 - Feb 07, 2022
Forward Dividend & Yield2.64 (2.97%)
Ex-Dividend DateMay 26, 2022
1y Target Est100.00
  • Motley Fool

    Why Shares in ScottsMiracle-Gro Slumped Today

    Its cannabis-related subsidiary, The Hawthorne Gardening Company, continues to suffer from overcapacity in the industry, and its sales declined a whopping 63%. In fact, the overall company's sales were so weak that it left the company with "higher leverage than we want to maintain," according to CEO Jim Hagedorn on the earnings release. As a reminder, the financial world typical gauges debt levels on the basis of earnings, so as its earnings outlook gets worse, so will Scotts come under pressure to reduce debt.

  • Zacks

    Scotts Miracle-Gro (SMG) Q3 Earnings Beat Estimates, Sales Miss

    Scotts Miracle-Gro (SMG) sees lower-than-expected sales in the U.S. Consumer segment and sustained pressure on sales in the Hawthorne unit in Q3.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Cannabis REIT IIPR generated record revenue of $70.5 million in the second quarter. Green Thumb Q2 revenue increased 5%, to $254 million. Scotts Miracle-Gro share price soared, despite the company missing earnings estimates. Key Takeaways; Psychedelic Sector Awakn received CA$2.5 government funding for phase III trial. July was a great month […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive.

Advertisement
Advertisement